trial · primary record
JNJ-90014496
Lymphoma, Non-Hodgkin
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 166 |
| Primary completion | 2041-07-30 |
| Primary endpoint | Phase 1b: Occurrence of Adverse Events (AEs) [Safety and Tolerability] |
| Registry ID | NCT05421663 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:01.394Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05421663
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.